Pharmaceutical

AbbVie’s Q2 2024 net earnings drop to $1.37bn

AbbVie has reported a 32.1% decrease in net earnings attributable to the company of $1.37bn in Q2 2024 from $2.02bn in Q2 last year.

Jul 28, 2024 - 04:00
AbbVie’s Q2 2024 net earnings drop to $1.37bn
AbbVie has reported a 32.1% decrease in net earnings attributable to the company of $1.37bn in Q2 2024 from $2.02bn in Q2 last year.
Read the original article

Tags:

Previous Article

Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn

Next Article

EC conditionally approves Pfizer’s haemophilia B gene therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Mid-year drug price hikes are back despite Inflation Reduction Act

STAT+: Mid-year drug price hikes are back despite Infla...

Aug 25, 2023

STAT+: Facing headwinds, Teladoc tests its bet on whole-person care

STAT+: Facing headwinds, Teladoc tests its bet on whole...

Apr 27, 2023

Opinion: The CDC’s new, relaxed Covid isolation guidance makes perfect sense

Opinion: The CDC’s new, relaxed Covid isolation guidanc...

Mar 6, 2024